A short catalytic enantioselective synthesis of the vascular antiinflammatory eicosanoid (11R,12S)-oxidoarachidonic acid

Organic Letters

Volumn 2, Issue 22, 2000, Pages 3437-3438

  Han, Xiaojun ^a   Crane, Sheldon N ^a   Corey, E J ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CATALYSIS; CHEMISTRY; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; STEREOISOMERISM; SYNTHESIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACIDS; CARDIOVASCULAR DISEASES; CATALYSIS; HUMANS; INFLAMMATION; STEREOISOMERISM;

EID: 0034597505     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol006430b     Document Type: Article

References (23)

1. Ross, R. N. Engl. J. Med. 1999, 340, 115.
2. Ridker, P. M.; Hennekens, C. H.; Buring, J. E.; Rafai, N. N. Engl. J. Med. 2000, 341, 836.
3. Schreyer, S. A.; Peschon, J. J.; LeBoeuf, R. C. J. Biol. Chem. 1996, 277, 26174.
4. De Groba, T. J. Neurobiol. 1997, 49, 515.
5. Strauss, D. S.; Pascuol, G.; Li, M.; Welch, J. S.; Ricote, M.; Hsiang, C.-H.; Sengchanthalangry, L. L.; Ghosh, G.; Glass, C. K. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 4844.
6. Thanos, D.; Maniatis, T. Cell 1995, 80, 529.
7. (a) Woronicz, J. D.; Gao, X.; Cao, Z.; Rothke, M.; Goeddel, D. V. Science 1997, 278, 866.
8. (b) Karin, M. J. Biol. Chem. 1999, 174, 27339.
9. Node, K.; Huo, Y.; Ruon, X.; Yang, B.; Spieckler, M.; Ley, K.; Zeldin, D. C.; Liao, J. K. Science 1999, 285, 1276.
10. (a) Quilley, J.; McGiff, J. C. Trends Pharmacol. Sci. 2000, 21, 121.
11. (b) Campbell, W. B. Trends Pharmacol. Sci. 2000, 27, 125.
12. Fisslthaler, B.; Popp, R.; Kiss, L.; Potente, M.; Harder, D. R.; Fleming, I.; Busse, R. Nature 1999, 401, 493.
13. Stuhlmeier, K. M.; Kao, J. J.; Bach, F. H. J. Biol. Chem. 1997, 272, 24679.
14. In contrast 5,6-, 8,9-, and 14,15-EET's were much less active in blocking IκB degradation.
15. Corey, E. J.; Marfat, A.; Falck, J. R.; Albright, J. O. J. Am. Chem. Soc. 1980, 102, 1433.
16. Falck, J. R.; Yadagiri, P.; Capdevila, J. Methods Enzymol. 1990, 187, 357.
17. Falck, J. R.; Manna, S.; Capdevila, J. Tetrahedron Lett. 1984, 25, 2443.
18. Mosset, P.; Yadagiri, P.; Lumin, S.; Capdevila, J.; Falck, J. R. Tetrahedron Lett. 1986, 27, 6035.
19. Han, X.; Corey, E. J. Org. Lett. 2000, 2, 2543. Eicosanoids 3 and 4 also enjoy an extraordinary resurgence of attention in current biomedical research.
20. (a) Sharpless, K. B.; Amberg, W.; Bennani, Y.; Crispino, G. A.; Hartung, J.; Jeong, K.-S.; Kwong, H.-L.; Morikawa, K.; Wang, Z.-M; Xu, D.; Zhang, X.-L. J. Org. Chem. 1992, 57, 2768.
21. (b) Wang, Z.; Zhang, X.; Sharpless, K. B.; Sinha, S. C.; Sinha-Bagchi, A.; Keinan, E. Tetrahedron Lett. 1992, 33, 6407.
22. Ylide 9 was prepared from the corresponding phosphonium salt by reaction with sodium hexamethyldisilazide in THF at -25 °C, see: (a) Zamboni, R.; Milette, S.; Rokach, J. Tetrahedron Lett. 1983, 24, 4899.
23. (b) Sandri, J.; Viala, J. J. J. Org. Chem. 1995, 60, 6627.